Your Patients Need Zavzpret — Here's How to Help Them Get It

You've determined that Zavzpret (Zavegepant) is the right treatment for your patient's acute migraines. The intranasal delivery avoids the GI absorption issues that plague many migraine patients, and the CGRP mechanism sidesteps the cardiovascular contraindications of triptans. It's the right clinical call.

But the prescription alone isn't enough. Your patient is likely going to face access challenges — from limited pharmacy stocking to insurance hurdles. This guide gives you a concrete, actionable workflow to maximize the likelihood that your patients actually receive their Zavzpret.

Current Availability: What to Expect

As of 2026, Zavzpret is not in a formal shortage. Pfizer's supply chain is intact. The challenge is at the retail pharmacy level:

• Many chain pharmacies do not routinely stock Zavzpret due to its high cost ($800–$1,100 per pack of 8 devices) and relatively low volume per location
• Independent pharmacies are variable but often more responsive to special orders
• Specialty and mail-order pharmacies are generally the most reliable channels

The key insight: the medication exists in the supply chain — the challenge is connecting your patient to the right pharmacy.

Why Patients Can't Find Zavzpret

Understanding the barriers helps you address them proactively:

Cost-Driven Stocking Decisions

At $800–$1,100 per pack, Zavzpret represents significant shelf investment for pharmacies. Unlike high-volume generics, the demand at any individual pharmacy location may not justify routine stocking. This is standard for newer specialty brands.

Insurance Prior Authorization Delays

The majority of payers require prior authorization for Zavzpret. Many also require step therapy documentation (typically a triptan trial and failure). When the PA isn't in place before the patient arrives at the pharmacy, the fill is rejected, and the patient leaves empty-handed.

Specialty Pharmacy Requirements

Some insurance plans mandate that Zavzpret be dispensed through specific specialty pharmacy networks. Patients may not learn about this requirement until their retail pharmacy attempts to process the claim.

Patient Awareness

Many patients don't know that they can request a special order, transfer prescriptions, or use tools to check pharmacy inventory. They may assume that if their pharmacy doesn't have it, it's unavailable.

What Providers Can Do: 5 Practical Steps

Step 1: Check Pharmacy Availability Before Prescribing

Use Medfinder for Providers to check which pharmacies in your patient's area currently have Zavzpret in stock. This takes seconds and prevents the most common failure point: sending a prescription to a pharmacy that doesn't carry it.

If the patient's preferred pharmacy doesn't stock Zavzpret, you can direct the prescription to one that does — or advise the patient to call ahead for a special order.

Step 2: Submit Prior Authorization Proactively

Don't wait for the pharmacy rejection to trigger the PA process. If you know the patient's plan requires prior authorization for Zavzpret (and most do), submit it at the time of prescribing. Include:

• Documented diagnosis of migraine
• Any prior triptan use and reasons for failure or contraindication
• Clinical rationale for intranasal delivery (e.g., significant nausea, vomiting during attacks)
• Any relevant comorbidities that preclude triptan use

Having the PA approved before the patient visits the pharmacy dramatically increases first-fill success rates.

Step 3: Provide Savings Program Information in the Exam Room

Cost is a major barrier for patients. Address it before they leave your office:

• Pfizer Savings Card: Commercially insured patients may qualify to pay as little as $0 per fill. The application can be started during the visit.
• Pfizer RxPathways: For uninsured or underinsured patients; may provide Zavzpret at no cost if income criteria are met.

Handing the patient a savings card or pointing them to Medfinder's savings guide ensures they don't abandon the prescription due to sticker shock at the pharmacy counter.

Step 4: Identify the Right Pharmacy Channel

Before sending the prescription, determine the optimal pharmacy channel:

• Retail pharmacy: Fine if the location stocks Zavzpret or the patient is willing to wait for a special order (1-3 days)
• Specialty pharmacy: Required by some plans; generally reliable but requires enrollment
• Mail-order pharmacy: Good for ongoing refills; initial fill may take longer

If the plan requires specialty pharmacy dispensing, help the patient initiate enrollment at the point of prescribing. Your staff can often start this process with a phone call.

Step 5: Follow Up on First Fill

A brief follow-up — even a quick message through your patient portal — to confirm the patient was able to fill the prescription can catch access problems before they escalate. If the first fill fails, you can troubleshoot immediately rather than learning about it weeks later at a follow-up visit.

Alternatives When Zavzpret Isn't Accessible

If access barriers prove insurmountable for a particular patient, these alternatives offer similar therapeutic benefit:

• Ubrelvy (Ubrogepant) 50 mg or 100 mg: Oral CGRP antagonist; same mechanism, different route. Good option when nausea isn't the primary concern.
• Nurtec ODT (Rimegepant) 75 mg: Orally disintegrating CGRP antagonist; dual indication for acute and preventive use. The ODT format helps with nausea-related compliance.
• Sumatriptan nasal spray 20 mg: Generic available; significantly more affordable. Contraindicated in cardiovascular disease.
• Trudhesa (Dihydroergotamine) nasal spray: Alternative intranasal option; ergot class; cardiovascular contraindications apply.

See the patient alternatives guide for comparisons you can share.

Workflow Tips for Your Practice

Integrating Zavzpret access management into your practice workflow doesn't have to be burdensome. Here are efficient approaches:

• Create a "Zavzpret prescribing checklist" for your staff: verify insurance coverage, submit PA, check pharmacy inventory, provide savings card information
• Designate 1-2 "go-to" pharmacies in your area that reliably stock Zavzpret and direct prescriptions there by default
• Use Medfinder for Providers as part of your prescribing workflow to check real-time availability
• Document step therapy failures thoroughly in the chart — this supports PA submissions and appeals
• Keep manufacturer support materials (savings card applications, RxPathways information) accessible in exam rooms

Final Thoughts

Zavzpret is a clinically valuable medication that fills a real gap in acute migraine treatment. The access challenges are real but predictable, and a proactive approach at the point of prescribing can resolve most of them.

By checking pharmacy availability, submitting prior authorizations early, connecting patients with savings programs, and choosing the right pharmacy channel, you can significantly improve your patients' experience and ensure they actually receive the treatment you've prescribed.

For the latest on Zavzpret availability, see our provider shortage briefing. And to check real-time pharmacy inventory, visit Medfinder for Providers.